continuous manufacturing

continuous manufacturing

featured image of Revolutionary Genomic Tech Promises Cheaper Animal Vaccines

Revolutionary Genomic Tech Promises Cheaper Animal Vaccines

BIOT

📅 June 3, 2024: High costs and technical difficulties limit animal vaccine development. 💉 New QTL technology offers affordable and effective vaccines. 🔬🚀

featured image of Revolutionary Cell Therapy Platform: Faster Cheaper and Automated!

Revolutionary Cell Therapy Platform: Faster Cheaper and Automated!

BIOT

🚀 Cytiva launches Sefia platform, speeding up cell-based treatments production. 💉 Sefia lowers costs, reduces errors, and saves time. 🔬 Scalable and flexible for all manufacturing stages. 💼 Direct marketing to customers.

featured image of Game-Changing Partnership: AGC Biologics and BioConnection Revolutionize Biodrug Development and Manufacturing

Game-Changing Partnership: AGC Biologics and BioConnection Revolutionize Biodrug Development and Manufacturing

BIOT

📢 AGC Biologics and BioConnection partner to offer end-to-end biopharmaceutical development and manufacturing services. 👥💊🌍⚠️🔒💡

featured image of Revolutionizing Cell Therapy Manufacturing: Cheaper and Accessible

Revolutionizing Cell Therapy Manufacturing: Cheaper and Accessible

BIOT

📰 Getting the Economical Edge on Cheaper Cell Therapy Manufacturing explores Alder Therapeutics' cost-effective approach to therapy development. 💰🔬🧪🔬🔬🌱

featured image of Revolutionary Partnership Automates Cell Therapy Manufacturing for Age-Related Diseases

Revolutionary Partnership Automates Cell Therapy Manufacturing for Age-Related Diseases

BIOT

🙌 Multiply Labs and Retro Biosciences partner to automate cell therapy manufacturing for age-related diseases, valued at $85 million. 🌍

featured image of Revolutionary Automation System Cuts Cell and Gene Therapy Costs by 70

Revolutionary Automation System Cuts Cell and Gene Therapy Costs by 70

BIOT

🤖 Vendor-agnostic automation system for cell and gene therapy manufacturing reduces errors and lowers costs.💡

featured image of Revolutionizing Cell Therapy Manufacturing: Faster & Safer

Revolutionizing Cell Therapy Manufacturing: Faster & Safer

BIOT

🔎 This article explores the challenges in cell therapy manufacturing and the urgency for faster processes. It discusses closed-process systems, bioreactors, and rapid testing methods to improve efficiency. It emphasizes the significance of streamlined manufacturing and quality control testing for faster treatment delivery. The need for a common manufacturing platform and scalability in cell therapy production is also addressed.

featured image of Merck Revolutionizes Biosafety Testing with Game-Changing Genetic Stability Assay

Merck Revolutionizes Biosafety Testing with Game-Changing Genetic Stability Assay

BIOT

Merck introduces a game-changing genetic stability assay for biosafety testing, simplifying and reducing time and costs. 🧬💼

featured image of Ascend Acquires GMP Facility Boosts Gene Therapy

Ascend Acquires GMP Facility Boosts Gene Therapy

BIOT

📢 Ascend Advanced Therapies secures Beacon Therapeutics' GMP facility in Florida, boosting gene therapy expertise and product supply. 🔬🤝👁️

featured image of Lonza Partners with Acumen for Alzheimer's Breakthrough

Lonza Partners with Acumen for Alzheimer’s Breakthrough

BIOT

📰 Lonza teams up with Acumen to make sabirnetug, a groundbreaking Alzheimer's therapy, at their New Hampshire facility. 👥 🧪 Sabirnetug targets toxic amyloid beta oligomers, offering hope in the fight against Alzheimer's. 💡 ⏩ Exciting collaboration to speed up Alzheimer's treatment development. Lonza Acumen AlzheimersTherapy Sabirnetug